UBS Group’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-551
| Closed | -$10K | – | 8004 |
|
|
2020
Q3 | $10K | Buy |
551
+215
| +64% | +$3.9K | ﹤0.01% | 6025 |
|
|
2020
Q2 | $5K | Sell |
336
-433
| -56% | -$6.44K | ﹤0.01% | 6556 |
|
|
2020
Q1 | $11K | Buy |
+769
| New | +$11K | ﹤0.01% | 5996 |
|
|
2019
Q4 | – | Sell |
-27,244
| Closed | -$419K | – | 7359 |
|
|
2019
Q3 | $419K | Buy |
27,244
+27,044
| +13,522% | +$416K | ﹤0.01% | 3857 |
|
|
2019
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 6537 |
|
|
2019
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 6286 |
|
|
2018
Q4 | $6K | Sell |
200
-2,921
| -94% | -$87.6K | ﹤0.01% | 6581 |
|
|
2018
Q3 | $109K | Buy |
3,121
+2,902
| +1,325% | +$101K | ﹤0.01% | 4661 |
|
|
2018
Q2 | $5K | Buy |
219
+19
| +10% | +$434 | ﹤0.01% | 6571 |
|
|
2018
Q1 | $5K | Sell |
200
-62
| -24% | -$1.55K | ﹤0.01% | 6377 |
|
|
2017
Q4 | $4K | Sell |
262
-31
| -11% | -$473 | ﹤0.01% | 6511 |
|
|
2017
Q3 | $8K | Buy |
+293
| New | +$8K | ﹤0.01% | 6109 |
|